Merck Announces its unique women-oriented initiative - 'Swasth Nari Shashkt Pariwar'
• Partners with non-profit organization Doctors For You. • Addresses the national issue of anaemia among women.
By: Merck Group
Under the first phase of the "Swasth Nari Sashkt Pariwar" program 5000 women from Lallubhai Compound, Mankhurd, Mumbai will undergo anaemia check and those found low on haemoglobin will be supported by Doctors for You over a four months period to take charge of their health and restore the haemoglobin levels. The NGO will focus on raising awareness on the harmful effect of low haemoglobin, improve understanding of the food and medicine supplements to restore haemoglobin and thereby encourage affected women to become anaemia free. An unique aspect of this initiative will be the skill development courses offered to those women who become anaemia free in the four months period.
"Women's health tends to be ignored in many of our societies and this has resulted in a national problem of more than fifty percent of our women being anaemic. With this purposeful program "Swasth Nari Sashkt Pariwar" Merck aims to bring about a significant change by helping women take charge of their nutrition needs and thereby become healthy and contribute more to the family they nurture. We are
very hopeful that we will have many success stories coming out of this initiative", said Anand Nambiar, Managing Director, Merck India.
As the world's oldest pharmaceutical and chemical company, Merck is committed to improving Access to Health (A2H) on a global scale: by making use of our core competencies, expertise and experience across the health value chain. Our programs and initiatives are tailored to global, regional and local needs, taking a holistic approach and working in partnerships. A2H work is a key element of our Corporate Responsibility strategy, and it cuts across different areas of our business.
For more information, visit www.merck.co.in or connect with us on Twitter, Facebook, LinkedIn and YouTube.
All Merck news releases are distributed by email at the same time they become available on the Merck website. Please go to www.merckgroup.com/
About Merck Merck is a leading science and technology company in healthcare, life science and performance materials. Around 50,000 employees work to further develop technologies that improve and enhance life – from biopharmaceutical therapies to treat cancer or multiple sclerosis, cutting-edge systems for scientific research and production, to liquid crystals for smartphones and LCD televisions. In 2017, Merck generated sales of € 15.3 billion in 66 countries.
Founded in 1668, Merck is the world's oldest pharmaceutical and chemical company. The founding family remains the majority owner of the publicly listed corporate group. Merck holds the global rights to the Merck name and brand. The only exceptions are the United States and Canada, where the company operates as EMD Serono, MilliporeSigma and EMD Performance Materials.